Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
Jingxin Li(Beijing Tongren Hospital), Tao Zhu, Weixue Si, Rong Tang(Jiangsu Provincial Center for Disease Control and Prevention), Jin Zhong, Wenjie Tan(Sinopec (China)), Jin-Bo Gou, Fengjuan Shi(Jiangsu Provincial Center for Disease Control and Prevention), Baoying Huang(National Institute for Viral Disease Control and Prevention), Lunbiao Cui(Jiangsu Provincial Center for Disease Control and Prevention), Fengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention), Zhuo-Pei Li(Nanjing Medical University), Xue Wang(Second Affiliated Hospital of Zhejiang University), Yin Chen(Southern Medical University), Xiaoqin Chen(North Sichuan Medical University), Xiaolong Zhao(China Pharmaceutical University), Rong Tang(Jiangsu Provincial Center for Disease Control and Prevention), Xiling Guo(Jiangsu Provincial Center for Disease Control and Prevention), Wei Chen(Academy of Military Medical Sciences), Hongxing Pan(Jiangsu Provincial Center for Disease Control and Prevention), Xiaoyu Xu, Shipo Wu(Academy of Military Medical Sciences)
Cited by 172
Related Papers
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
|The Lancet Infectious Diseases|2020|1.5k
Co-infection with respiratory pathogens among COVID-2019 cases
|Virus Research|2020|637
SoNar, a Highly Responsive NAD+/NADH Sensor, Allows High-Throughput Metabolic Screening of Anti-tumor Agents
|Cell Metabolism|2015|428
Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China
|The Journal of Infectious Diseases|2020|391
A Family Cluster of Infections by a Newly Recognized Bunyavirus in Eastern China, 2007: Further Evidence of Person-to-Person Transmission
|Clinical Infectious Diseases|2011|268